Your New Therapist: Chatty, Leaky, and Hardly Human
If you or someone you know may be experiencing a mental health crisis, contact the…
If you or someone you know may be experiencing a mental health crisis, contact the 988 Suicide & Crisis Lifeline by dialing or texting “988.” Vince Lahey of Carefree, Arizona, embraces chatbots. From Big Tech products to “shady” ones, they offer “someone that I could share more secrets with than my therapist.” He especially likes…
LISTEN: Quashing innovation or risking a patient’s health? Lauren Sausser told WAMU’s Health Hub on April 15 why the White House and some states are at odds over how to regulate AI in health care. Speed, efficiency, and lower costs. Those are the traits artificial intelligence supporters celebrate. But the same qualities worry physicians who…
By MIKE MAGEE Stanford neuroscientist, David Eagleman, reminded us this week that “A coherent explanation of consciousness eludes modern science.” That was his opening line in the New York Times book review of Michael Pollan’s latest effort, “A World Appears.” In it, Pollan asks innocently, “How does the brain generate a unified sense of self?”…
Wisp partnered with Visby Medical to expand access to Visby’s at-home sexually transmitted infection test and provide follow-up treatment through Wisp’s telehealth platform. The post Wisp, Visby Partner to Expand Access to At-Home STI Test appeared first on MedCity News.
CMS is rolling out its health tech ecosystem initiative with a new Medicare app library that functions like a healthcare “App Store,” aiming to make patient data more portable and accessible across vetted digital health apps. The post CMS’ New ‘App Store’ Is Trying to Turn Interoperability Into a Digital Health Distribution System appeared first…
The fatty liver disease MASH is one of the metabolic disorders that Nula Therapeutics is pursuing. The startup’s small molecules are intended to restore the integrity of the nuclear envelope, a cellular membrane whose dysfunction can contribute to metabolic disease. The post Startup Nula Emerges to Advance a New Class Medicines for Metabolic Disease appeared…
Innovations in biomarker science, particularly in cerebrospinal fluid (CSF) and blood, are expanding Alzheimer’s testing beyond specialty care. The post The Key Biomarkers Changing How and When We Diagnose Alzheimer’s Disease appeared first on MedCity News.
The difference between that last era and this one isn’t incremental. It’s categorical. Artificial intelligence isn’t optimizing the old system. It’s making the old system economically indefensible. The post The End of Incrementalism: Why Healthcare Innovation is Finally Reshaping the Model appeared first on MedCity News.
The number of babies born in the United States fell again last year. According to new data from the Centers for Disease Control and Prevention, there were 3.6 million births in 2025, a 1% decline from 2024. The fertility rate dropped to 53.1 births per 1,000 women ages 15 to 44, down 23% since 2007….